The CBRF-BRIF funds are a crucial element in supporting the Government of Canada’s Biomanufacturing and Life Sciences Strategy. This program is designed to build on existing assets and infrastructure, promoting highly collaborative projects including partners from academia, industry, government, and the nonprofit sector, to prepare Canada for the next pandemic and build our national biomanufacturing capacity.
CASTL is pleased to be a partner in the following hubs:
Led by The University of British Columbia. Helping develop next-generation immune-based therapeutics that can be manufactured domestically using the latest innovations in biomanufacturing in response to pandemics.
Led by the University of Montreal. Increasing the agility, connectivity and growth of the biomanufacturing and life sciences sector to ensure that Canada is prepared for future pandemics and public health crises.
Led by the University of Ottawa and McMaster University. Catalyzing research and biomanufacturing innovations to help Canada produce vaccines, therapeutics and diagnostics ahead of future pandemics.
Led by the University of Toronto. Advancing the concept of “personalized and precise medicine” to influence the development of vaccines, therapeutics and other public health interventions.
The PRAIRIE Hub for Pandemic Preparedness is one of five national pandemic preparedness hubs created in 2023 through Stage 1 of the integrated Canadian Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF) competition.
The PRAIRIE Hub is led by the University of Alberta, and includes the University of Manitoba, Calgary, Saskatchewan/VIDO as major partners and many other partners across multiple sectors in the Hub region.
CASTL partnered with the University of British Columbia School of Biomedical Engineering (UBC SBME) to deliver ‘Introduction to Biopharmaceutical Manufacturing’ to undergraduate students. The course was designed to provide students with a comprehensive understanding of the scientific and engineering challenges present in the manufacturing of biopharmaceutical products. |
The University of Prince Edward Island (UPEI) has developed a Minor in Biotechnology. Launched in January 2022, this program provides students with skills that are valued by industry stakeholders. It also serves as a gateway for students to pursue further studies related to CASTL priority areas including the biotechnology articulation program. |
BCIT is partnering with CASTL to create a new biomanufacturing training facility at BCIT to deliver training and build the talent pool to meet the needs of the growing life sciences and biomanufacturing industry. The new National Biomanufacturing Training Centre (NBTC) will be the first of its kind in B.C. (Opening Spring 2024). |
Bio |
Bio |
Bio |